Forced vital capacity, airway obstruction and survival in a general population sample from the USA

Thorax

Volumn 66, Issue 1, 2011, Pages 49-54

  Burney, P G J ^a   Hooper, R ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SPIROMETRY; SURVIVAL; UNITED STATES;

EID: 78650211882     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.147041     Document Type: Article

References (47)

1. Beaty TH, Cohen BH, Newill CA, et al. Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol 1982;116:102-13.
2. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983;128:491-500.
3. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and outcome of myocardial infarction. N Engl J Med 1976;295:1323.
4. Lange P, Nyboe J, Jensen G, et al. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J 1991;4:1080-7.
5. Sin D, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? the potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-19.
6. Anderson HR, Vallance P, Bland JM, et al. Prospective study of mortality associated with chronic lung disease and smoking in Papua New Guinea. Int J Epidemiol 1988;17:56-61.
7. The ARIC Investigators. The Atherosclerosis Risk In Communities (ARIC) study: design and objectives. Am J Epidemiol 1989;129:687-702.
8. Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
9. Anon. ATS statement - Snowbird workshop on standardization of spirometry. Am Rev Respir Dis 1979;119:831-8.
10. Olofson J, Skoogh BE, Bake B, et al. Mortality related to smoking habits, respiratory symptoms and lung function. Eur J Respir Dis 1987;71:69.
11. Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the cardiovascular health study. JAMA 1998;279:585-92.
12. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 1983;105:311.
13. Keys A, Aravanis C, Blackburn H, et al. Lung function as a risk factor for coronary heart disease. Am J Public Health 1972;62:1506.
14. Hyatt R, Cowl C, Bjoraker J, et al. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest 2009;135:419.
15. Stǎnescu D. Small airways obstruction syndrome. Chest 1999;116:231.
16. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010;35:676.
17. Kan H, Heiss G, Rose K, et al. Traffic exposure and lung function in adults: the atherosclerosis risk in communities study. Thorax 2007;62:873.
18. Schroeder E, Welch V, Couper D, et al. Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol 2003;158:1171.
19. Yeh H, Punjabi N, Wang N, et al. Vital capacity as a predictor of incident type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005;28:1472.
20. Kaminsky D. Spirometry and diabetes: implications of reduced lung function. Diabetes Care 2004;27:837.
21. Yeh H, Punjabi N, Wang N, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes Care 2008;31:741.
22. Barker DJP, Godfrey KM, Fall C, et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991;303:671-5.
23. Lopuhaa CE, Roseboom TJ, Osmond C, et al. Atopy, lung function and obstructive airways disease after prenatal exposure to famine. Thorax 2000;55:555-61. (Pubitemid 30398269)
24. Lima RdC, Victora C, Menezes AMB, et al. Respiratory function in adolescence in relation to low birth weight, preterm delivery, and intrauterine growth restriction. Chest 2005;128:2400-7.
25. He Q-, Wong T-, Du L, et al. Birth weight and lung function in a cohort of Chinese school children. Pediatr Pulmonol 2009;44:662-8.
26. Rona RJ, Gulliford MC, Chinn S. Effects of prematurity and interuterine growth on respiratory health and lung function in childhood. BMJ 1993;306:817-20.
27. Orfei L, Strachan DP, Rudnicka AR, et al. Early influences on adult lung function in two national British cohorts. Arch Dis Child 2008;93:570-4. (Pubitemid 352030077)
28. Stein CE, Kumaran K, Fall CHD, et al. Relation of fetal growth to adult lung function in south India. Thorax 1997;52:895-9.
29. Edwards CA, Osman LM, Godden DJ, et al. Relationship between birth weight and adult lung function: controlling for maternal factors. Thorax 2003;58:1061-5.
30. Dezateux C, Lum S, Hoo A, et al. Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis. Thorax 2004;59:60-6.
31. Canoy D, Pekkanen J, Elliott P, et al. Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax 2007;62:396-402.
32. Hancox RJ, Poulton R, Greene JM, et al. Associations between birth weight, early childhood weight gain and adult lung function. Thorax 2009;64:228-32.
33. Pei L, Chen G, Mi J, et al. Low birth weight and lung function in adulthood: retrospective cohort study in China, 1948e1996. Pediatrics 2010;125:e899-905.
34. Huxley R, Owen C, Whincup P, et al. Is birth weight a risk factor for ischemic heart disease in later life? Am J Clin Nutr 2007;85:1244-50.
35. Whincup P, Kaye S, Owen C, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008;300:2886-97.
36. Nakajima K, Kubouchi Y, Muneyuki T, et al. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 2008;134:712-18.
37. Lee H, Chung S, Lopez V, et al. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes. Chest 2009;136:171-6.
38. Gan WQ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80.
39. Engström G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002;106:2555-60. (Pubitemid 35340691)
40. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165.
41. Sattar N, McConnachie A, O'Reilly D, et al. Inverse association between birth weight and C-reactive protein concentrations in the MIDSPAN family study. Arterioscler Thromb Vasc Biol 2004;24:583-7.
42. Tzoulaki I, Jarvelin M, Hartikainen A, et al. Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: Northern Finland 1966 birth cohort study. Eur Heart J 2008;29:1049-56.
43. Canoy D, Pouta A, Ruokonen A, et al. Weight at birth and infancy in relation to adult leukocyte count: a population-based study of 5619 men and women followed from the fetal period to adulthood. J Clin Endocrinol Metab 2009;94:1916-22.
44. Pirkola J, Vääräsmäki M, Ala-Korpela M, et al. Low-grade, systemic inflammation in adolescents: association with early-life factors, gender, and lifestyle. Am J Epidemiol 2010;171:72-82.
45. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Medical Communications Resources, 2008. http://www.goldcopd. org.
46. Celli B, Cote C, Marin J, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005.
47. Puhan M, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009;374:704-11.